Cytosorbents Newsroom

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

BenzingaNov 13 01:37

CytoSorbents Analyst Ratings

BenzingaNov 13 01:36

Balanced Hold Rating Amid Revenue Miss and Strategic Initiatives at CytoSorbents

TipRanksNov 11 19:31

H.C. Wainwright Maintains Cytosorbents(CTSO.US) With Hold Rating, Maintains Target Price $1

Futu NewsNov 11 19:31

Cytosorbents Price Target Maintained With a $10.00/Share by EF Hutton

Dow JonesNov 5 01:35

Cytosorbents Is Maintained at Buy by EF Hutton

Dow JonesNov 5 01:35

CytoSorbents Analyst Ratings

BenzingaNov 5 01:26

B.Riley Financial Maintains Cytosorbents(CTSO.US) With Buy Rating, Cuts Target Price to $3

Futu NewsOct 3 02:31

CytoSorbents Analyst Ratings

BenzingaOct 2 03:52

Cytosorbents Price Target Maintained With a $10.00/Share by EF Hutton

Dow JonesAug 15 00:43

CytoSorbents Analyst Ratings

BenzingaAug 14 20:00

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

BenzingaAug 14 20:00

CytoSorbents Stability and Growth Prospects Maintain 'Hold' Rating Amid FDA Submission Uncertainty

TipRanksAug 14 18:37

H.C. Wainwright Maintains Cytosorbents(CTSO.US) With Hold Rating, Maintains Target Price $1

Futu NewsAug 14 18:31

EF Hutton Maintains Cytosorbents(CTSO.US) With Buy Rating, Raises Target Price to $10

Futu NewsJul 30 21:54

CytoSorbents Analyst Ratings

BenzingaJul 29 19:28

EF Hutton Initiates Coverage On CytoSorbents With Buy Rating, Announces Price Target of $10

BenzingaJul 29 19:28

B. Riley Securities: Reiterated CytoSorbents (CTSO.US) rating and adjusted from buy to buy rating, target price of $3.00.

Zhitong FinanceMay 15 22:10

CytoSorbents Analyst Ratings

BenzingaMay 15 22:10

Hold Rating on Cytosorbents Amid Regulatory Uncertainties and Mixed Clinical Results

TipRanksMay 7 19:51